This page contains a Flash digital edition of a book.
Management of asthmatic adolescents
Correct diagnosis and identifying comorbidities in asth-
diagnosis of respiratory diseases in primary care. Prim Care Respir J.
matic adolescents and regular assessment of asthma control
2006;15(1):20–34.
20. Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung
is essential to good disease management. Patients, parents,
function tests. Eur Respir J. 2005;26(5):948–968.
and physician must know what good asthma control is, i.e.,
21. Xuan W, Marks GB, Toelle BG, et al. Risk factors for onset and remission
what does well-controlled asthma look like. Asthma manage- of atopy, wheeze, and airway hyperresponsiveness. Thorax. 2002;57:104–
ment includes many therapy modalities: asthma education,
109.
environmental control, and pharmacotherapy. Implemen-
22. de Marco R, Locatelli F, Sunyer J, Burney P. Differences in incidence of
reported asthma related to age in men and women. A retrospective
tation of the international guidelines by physicians treating
analysis of the date of the European Respiratory Health Survey. Am J Respir
adolescents with asthma is fundamental to reduce the
Crit Care Med. 2000;162:68–74.
incidence of uncontrolled asthma. Today, knowledge of the 23. Wood RA. Skin testing: making the most of every prick. Ann Allergy
disease and effective medication are available, which give
Asthma Immunol. 2002;88:347–349.
hope and opportunity for significant improvement in the
24. de Benedictis D, Bush A. The challenge of asthma in adolescence. Pediatr
Pulmonol. 2007;42:683–692.
management of asthmatic adolescents.
25. McCauley E, Katon W, Russo J, Richardson L, Lozano P. Impact of
Disclosure: The authors declare no conflict of interest. The
anxiety and depression on functional impairment in adolescents with
authors did not receive any funding for this project.
asthma. Gen Hosp Psychiatry. 2007;29:214–222.
26. Sauty A, Prosper M. The hyperventilation syndrome. Rev Med Suisse. 2008;
180:2502–2505.
REFERENCES 27. Place R, Morrison A, Arce E. Vocal cord dysfunction. J Adolesc Health.
1. World Health Organization. Asthma. Geneva: WHO; 2008.
2000;27(2):125–129.
2. Masoli M, Fabian D, Holt S, Beasley R. for the Global Initiative for
28. Juniper EF, Buist AS, Cox FM, Ferrie PJ, King DR. Validation of a
Asthma (GINA) Program. The global burden of asthma: executive
standardized version of the Asthma Quality of Life Questionnaire. Chest.
summary of the GINA Dissemination Committee report. Allergy. 2004;59:
1999;115:1265–1270.
469–478.
29. Nathan RA, Sorkness CA, Kosinski M, et al. Development of the asthma
3. Pearce N, Ait-Khaled N, Beasley R, et al. Worldwide trends in the
control test: a survey for assessing asthma control. J Allergy Clin Immunol.
prevalence of asthma symptoms: phase III of the International Study of
2004;113:59–65.
Asthma and Allergies in Childhood (ISAAC). Thorax. 2007;62:758–765.
30. Vollmer WM, Markson LE, O’Connor E, et al. Association of asthma
4. Weiss KB, Sullivan SD. The health economics of asthma and rhinitis. I.
control with health care utilization and quality of life. Am J Respir Crit Care
Assessing the economic impact. J Allergy Clin Immunol. 2001;107:3–8.
Med. 1999;160:1647–1652.
31. Boulet LP, Boulet V, Milot J. How should we quantify asthma control? A
5. Antonicelli L, Bucca C, Neri M, et al. Asthma severity and medical
proposal. Chest. 2002;122:2217–23.
resource utilisation. Eur Respir J. 2004;23:723–729.
32. Kharitonov S, Alving K, Barnes PJ. Exhaled and nasal nitric oxide
6. Breekveldt-Postma NS, Erkens JA, Aalbers R, van de Ven MJ, Lammers
measurements: recommendations. The European Respiratory Society
JW, Herings RM. Extent of uncontrolled disease and associated medical
Task Force. Eur Respir J. 1997;10(7):1683–1693.
costs in severe asthma—a PHARMO study. Curr Med Res Opin. 2008;24(4):
33. Pizzichini MM, Popov TA, Efthimiadis A, et al. Spontaneous and induced
975–983.
sputum to measure indices of airway inflammation in asthma. Am J Respir
7. Accordini S, Bugiani M, Arossa W, et al. Poor control increases the
Crit Care Med. 1996;154(4 Pt 1):866–869.
economic cost of asthma. A multicentre population-based study. Int Arch
34. Green RH, Brightling CE, McKenna S, et al. Asthma exacerbations and
Allergy Immunol. 2006;141:189–198.
sputum eosinophil counts: a randomised controlled trial. Lancet. 2002;
8. Zeiger RS, Hay JW, Contreras R, et al. Asthma costs and utilization in a
360(9347):1715–1721.
managed care organization. J Allergy Clin Immunol. 2008;121:885–892, e5.
35. Smith AD, Cowan JO, Brassett KP, Herbison GP, Taylor DR. Use of
9. Sullivan SD, Wenzel SE, Bresnahan BW, et al. Association of control and
exhaled nitric oxide measurements to guide treatment in chronic asthma.
risk of severe asthma-related events in severe or difficult-to-treat asthma
N Engl J Med. 2005;352(21):2163–2173.
patients. Allergy. 2007;62:655–660.
36. Shaw DE, Berry MA, Thomas M, et al. The use of exhaled nitric oxide to
10. Holgate ST, Price D, Valovirta E. Asthma out of control? A structured
guide asthma management: a randomized controlled trial. Am J Respir Crit
review of recent patient surveys. BMC Pulm Med. 2006:6(Suppl 1):S2.
Care Med. 2007;176(3):231–237.
11. Horne R, Price D, Cleland J, et al. Can asthma control be improved by
37. Ostrov MR, Ostrov E. The self-image of asthmatic adolescents with
understanding the patient’s perspective? BMC Pulm Med. 2007:7:8.
asthma. J Asthma. 1986;23(4):187–193.
12. Barnes PJ. The size of the problem of managing asthma. Respir Med. 2004;
38. Tercyak KP. Psychosocial risk factors for tobacco use among adolescents
98(Suppl 2):S4–S8.
with asthma. J Pediatr Psychol. 2003;28:495–504.
13. Chapman KR, Boulet LP, Rea RM, Frenssen E. Suboptimal asthma
39. Using beta2-stimulants in asthma. Drug Ther Bull. 1997;35:1–4.
control: prevalence, detection and consequences in general practice. Eur
40. Godfrey S, Bar-Yishay E. Exercise-induced asthma revisited. Respir Med.
Respir J. 2008;31(2):320–325.
1993;87:331–344.
14. Ohar JA. Asthma treatment guidelines: current recommendations, future
41. Juniper EF, Kline PA, Vanzieleghem MA, Ramsdale EH, O’Byrne PM,
goals. P & T Digest. 2005;2(6):23–27.
Hargreave FE. Effect of long-term treatment with an inhaled corticoster-
15. Long AA. Addressing unmet needs in asthma care. P & T Digest. 2005;
oid (budesonide) on airway hyperresponsiveness and clinical asthma in
2(6):16–22.
nonsteroid-dependent asthmatics. Am Rev Respir Dis. 1990;142:832–836.
16. Schatz M. Pharmacotherapy of asthma: what do the 2007 NAEPP
42. The Childhood Asthma Management Program Research Group. Long
guidelines say? Allergy Asthma Proc. 2007;28(6):628–633.
term effects of budesonide or nedocromil in children with asthma. N Engl
17. US Department of Health and Human Services, National Institutes of J Med. 2000;343:1054–1063.
Health, National Heart, Lung, and Blood Institute: National Asthma 43. Jeffery PK, Godfrey RW, Adelroth E, Nelson F, Rogers A, Johansson SA.
Education and Prevention Program. Expert Panel Report 3: Guidelines for the Effects of treatment on airway inflammation and thickening of basement
Diagnosis and Management of Asthma. NIH Publication No. 07-40511-440; membrane reticular collagen in asthma. A quantitative light and electron
2007. microscopic study. Am Rev Respir Dis. 1992;145:890–899.
18. The Global Strategy for Asthma Management and Prevention. Global 44. Pauwels RA, Lofdahl CG, Postma DS, et al. Effect of inhaled formoterol
Initiative for Asthma (GINA); 2008. and budesonide on exacerbations of asthma. Formoterol and
19. Levy ML, Fletcher M, Price DB, Hausen T, Halbert RJ, Yawn BP. Corticosteroids Establishing Therapy (FACET) International Study
International Primary Care Respiratory Group (IPCRG) Guidelines: Group. N Engl J Med. 1997;337:1405–1411.
www.slm-respiratory.com 67 AoRM 2010; 1:(1). February 2010
Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100  |  Page 101  |  Page 102  |  Page 103  |  Page 104  |  Page 105  |  Page 106  |  Page 107  |  Page 108  |  Page 109  |  Page 110  |  Page 111  |  Page 112  |  Page 113
Produced with Yudu - www.yudu.com